With the number of opioid-related deaths in Canada set to exceed 3,000, the nation’s government has announced new measures to tackle the epidemic but admits that these alone will not change the current course of events.
In 2016, the lives of 2,800 Canadians were taken by the crisis and preliminary data suggests that this year, the number will be at least 7% higher than that.
Government department Health Canada has called this loss of life ‘nothing short of tragic’ and has dubbed the issue a national public health crisis.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze